ArticlebioRxiv : the preprint server for biology2025
R2HaPpY: Rapid-robust phosphotyrosine peptide enrichment using HaloTag-Src SH2 pY superbinder.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Phosphotyrosine signaling plays a critical role in many biological processes, from cell proliferation to immune response. Despite its importance, systems-level analysis of phosphotyrosine signaling remains a challenge due to costly enrichment reagents and labor-intensive protocols. We previously established an automated phosphotyrosine enrichment method for preparing 96 samples in parallel. Here, we further optimize this method by fusing an SH2 phosphotyrosine superbinder to the HaloTag protein. This allows simple and cost-effective preparation of enrichment beads directly from bacterial lysate, expediting reagent preparation from days to hours. Additionally, our new reagent binds phosphotyrosine peptides at higher efficiency than other enrichment reagents. Using this reagent, we detect and quantify 1,651 unique phosphotyrosine sites from EGF stimulated HeLa cells using only ~1 mg of input peptides per replicate. These include 878 regulated pY sites, many of which are low abundance and not previously detected or annotated as EGF-responsive. This streamlined and sensitive method facilitates comprehensive, quantitative mapping of tyrosine phosphorylation dynamics, enabling broader integration of phosphotyrosine signaling into multiomic and network-level models across diverse biological systems and disease states.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.